At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Eksodevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Performance Attributes and User Progression While Using Ekso Robotic Exoskeleton in an Eight Week, Over Ground, Locomotor Program in Individuals With Spinal Cord Injury
In Brief
A clinical study evaluating Ekso for Spinal Cord Injury. Completed, enrolled 60 participants across 9 sites in 7 countries.
Detailed Summary
This study is to evaluate the performance attributes and user progression of participants with motor complete and incomplete spinal cord injury (SCI) while utilizing the Ekso robotic exoskeleton in an eight week over ground, locomotor program. We hypothesize an improvement in progression and overall health while using Ekso.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpinal Cord Injury
CountriesDenmark, Germany, Netherlands, Norway, Spain, Sweden, Switzerland
CollaboratorsGlostrup University Hospital, Copenhagen
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 2014
Enrollment StartAug 2014
Primary CompletionJan 2017
TodayJul 2026
First PostedMay 7, 2014
Enrollment StartAug 1, 2014
Primary CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 12.2 years ago
Interventions
Eksodevice